Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

Movement Disorders

Volumn 21, Issue 5, 2006, Pages 704-707

  Lagalla, Giovanni ^a   Millevolte, Marzia ^a   Capecci, Marianna ^a   Provinciali, Leandro ^a   Ceravolo, Maria Gabriella ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Botox; Botulinum toxin type A; Drooling; Parkinson's disease

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; FAMILY RELATION; FEMALE; FISHER EXACT TEST; HUMAN; HYPERSALIVATION; MALE; PARKINSON DISEASE; PAROTID GLAND; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK REDUCTION; SOCIAL DISABILITY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

AGED; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PARKINSON DISEASE; SIALORRHEA;

EID: 33646925831     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20793     Document Type: Article

References (12)

1. Bateson MC, Gibberd FB, Wilson RSE. Salivary symptoms in Parkinson's disease. Arch Neurol 1973;14:13-22.
2. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment: botulinum toxin A injections of the parotid glands. Med Hypothesis 1997;48:337-339.
3. Porta M, Gamba M, Bertacchi G, Vaj P. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injections in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538-540.
4. Pal PK, Calne DB, Calne S, Tsui JKC. Botulinum toxin A as treatment for drooling saliva in PD. Neurology 2000;54:244-247.
5. Winterholler MGM, Erbguth FJ. Botulinum toxin for the treatment of sialorrhoea. in ALS: serious side effects of a transductal approach. J Neurol Neurosurg Psychiatry 2001;70:406-425.
6. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C, Beuche W. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope 2002;112:82-86.
7. Bhatia KP, Munchau A, Brown P. Botulinum toxin is a useful treatment in excessive drooling of saliva. J Neurol Neurosurg Psychiatry 1999;67:697.
8. Jost WH. Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 1999;14:1057-1059.
9. Tan EK, Lo YL, Seah A, Auchus AP. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. J Neurol Sci 2001;190:95-97.
10. Lipp A, Trottenberg T, Schink A, Kupsch A, Arnold G. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 2003;61:1279-1281.
11. Mancini F, Zangaglia, P, Silvano C, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C. Double blind, placebo controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in Parkinsonism. Mov Disord 2003;18:685-688.
12. Dogu O, Apaydin D, Sevim S, Talas DU, Aral M. Ultrasound-guided versus "blind" intraparotid injections of botulinum toxin A for the treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg 2004;106:93-96.